Abstract:Background: Diphenhydramine is frequently misused and ingested recreationally for its antihistaminergic and antimuscarinic effects and is often involved in both serious and fatal poisonings, either in isolation or in combination with other xenobiotics. Objective: This analysis sought to determine which patient and encounter characteristics were associated with severe outcome after diphenhydramine overdose. Methods: This is an analysis of the multi-center ToxIC registry (2010-2016). Descriptive analysis of all cases with diphenhydramine listed as the "primary agent" contributing to toxicity were included. Analysis sought to determine which patient and encounter characteristics were associated with severe outcome, defined as occurrence of seizure, ventricular dysrhythmia, or intubation. To determine which patient and encounter characteristics were individually associated with severe outcome, we performed chi-square tests. Fisher's exact tests were used in the case of sparse data. We also performed multivariable logistic regression to further determine independent risk factors for severe outcome in diphenhydramine overdose. Results: Eight hundred and sixty-three cases remained after exclusion with 15.6% (n = 135) of all patients having one or more severe outcome. The most common severe outcome was seizures which occurred in 98 (11.6%) of all ingestions. Females comprised 59.1% (n = 510) of all ingestions. Most ingestions were intentional (86.0%, n = 742) with the most common known reason for an intentional ingestion being self-harm, accounting for 37.5% (n = 324) of all ingestions. Self-harm ingestions and ingestions in males were more commonly associated with intubation. When examining outcomes by age, there were no significant differences overall or in any individual outcome except intubation in which children 0-12 were less likely to be intubated as compared to teens and adults. Signs and symptoms most strongly associated with a severe outcome included acidemia (pH < 7.2), QRS prolongation (QRS > 120 ms), and elevated anion gap (AG > 20). Discussion: Acidemia, QRS prolongation, and elevated anion gap are associated with severe outcomes in diphenhydramine toxicity. Further research is warranted to determine their predictive characteristics.

Diphenhydramine-involved Fatal and Nonfatal Drug Overdoses in Tennessee, 2019–2022

Treating Diphenhydramine Overdose: A Literature Review of Currently Available Treatment Methods

Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicity

Fatal Diphenidol Poisoning: a Case Report and a Retrospective Study of 16 Cases

Postmortem diphenhydramine blood concentrations in children

An examination of fatal child poisonings in the United States using the National Violent Death Reporting System (NVDRS), 2012-2017

Tianeptine-involved emergency department visits, fatal overdoses, and substance seizures in Tennessee, 2021-2023

Forensic Analysis of 9 Poisoning Death Cases Caused by Oral Administration of Diphenidol.

The value of machine learning for prognosis prediction of diphenhydramine exposure: National analysis of 50,000 patients in the United States

Over-the-counter medications encountered in the postmortem pediatric population from 2010-2020

Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021

Benzonatate Exposure Trends and Adverse Events

S4684 Rare Case of Drug-Induced Liver Injury Secondary to Benadryl Use

Pediatric ADHD Medication Exposures Reported to US Poison Control Centers

Trends in Drug Overdose Deaths by Intent and Drug Categories, United States, 1999‒2022

Pharmaceutical Drug Poisoning after Deregulation of Over the Counter Drug Sales: Emergency Department Based In-depth Injury Surveillance

HYPERTENSION AND DEXTROMETHORPHAN POISONING IN PATIENTS AGED BETWEEN 0 TO 18 YEARS- A 7 YEAR RETROSPECTIVE CASE SERIES

Two Cases of Dextromethorphan Overdose Reversed by Naloxone

Prescription Drug Monitoring Programs and Drug Overdose Deaths Involving Benzodiazepines and Prescription Opioids.

Over-the-counter analgesic-related exposure and toxicity in pediatrics

Abuse and Intentional Misuse of Promethazine Reported to US Poison Centers: 2002 to 2012